Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the Toraymyxin therapeutic... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
EDTXF is expected to report earnings to fall 66.67% to 0 cents per share on March 26
Q4'25
Est.
$-0.01
Q4'23
Missed
by $0.02
Q3'23
Est.
$-0.01
Q2'23
Est.
$-0.01
Q1'23
Est.
$-0.01
The last earnings report on March 28 showed earnings per share of -2 cents, missing the estimate of 0 cents. With 5.00K shares outstanding, the current market capitalization sits at 292.91M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. EDTXF showed earnings on March 28, 2024. You can read more about the earnings report here.